Skip To Main Content
Andrea Delbarba on Muck Rack

Andrea Delbarba

As seen in: Wiley Online Library, MDPI, JAMA Network, The Lancet, Managing Intellectual Property
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrea

Contact Andrea, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors

|
By Deborah Cosentini, Marco Ravanelli, Laura Moretti, Gherardo Mazziotti, Andrea Delbarba, Salvatore Grisanti, Marta Laganà, Antonella Turla, Carlo Cappelli, Davide Farina, Stefano Calza, Francesco Donato, Alfredo Berruti, Rebecca Pedersini, Greta Schivardi, Giulia Scartabellati, Michela Bazzoli, Salvatore Strazzeri, Emanuele Dalla Chiara
| JAMA Network Verified
Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors Supplement 1. eTable 1. Baseline Clinicopathological, Densitometric, and Body Composition Characteristics by Obesity Status, Classified According to Occurrence of FM% Greater Than 40.8% at Any Assessment During Follow-Up eTable 2. Clinicopathological, Densitometric and Body Composition Characteristics of the Study Population at Baseline, 18 Months, 36 Months, and 5 Years of Follow-Up eTable 3.
Open in Who Shared Issue with article?

Extending innovation: navigating SPCs and paediatric extensions in the EU

|
By Andrea Delbarba, Claudia Finetti
| Managing Intellectual Property Verified
The supplementary protection certificate (SPC) is a legal instrument designed to extend the protection conferred by a basic patent for certain pharmaceutical and plant protection products in the EU. Its primary purpose is to compensate for the time lost between the filing of a patent and the granting of marketing authorisation, during which the product cannot be commercially exploited.
Open in Who Shared Issue with article?

Effect of Oral Bisphosphonates on Vertebral Fractures in Males Living with HIV: A Seven Year Study

|
By Letizia Chiara Pezzaioli, Teresa Porcelli, Andrea Delbarba, Giorgio Tiecco
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 6 articles